OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors
Jan‐Paul Bohn, Georg Pall, Guenther Stockhammer, et al.
Targeted Oncology (2016) Vol. 11, Iss. 3, pp. 263-275
Closed Access | Times Cited: 20
Jan‐Paul Bohn, Georg Pall, Guenther Stockhammer, et al.
Targeted Oncology (2016) Vol. 11, Iss. 3, pp. 263-275
Closed Access | Times Cited: 20
Showing 20 citing articles:
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Christopher M. Hartshorn, Michelle S. Bradbury, Gregory M. Lanza, et al.
ACS Nano (2017) Vol. 12, Iss. 1, pp. 24-43
Open Access | Times Cited: 233
Christopher M. Hartshorn, Michelle S. Bradbury, Gregory M. Lanza, et al.
ACS Nano (2017) Vol. 12, Iss. 1, pp. 24-43
Open Access | Times Cited: 233
Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
Nicola Colclough, Kan Chen, Peter Johnström, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 1, pp. 189-201
Open Access | Times Cited: 169
Nicola Colclough, Kan Chen, Peter Johnström, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 1, pp. 189-201
Open Access | Times Cited: 169
Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
Sheheryar Kabraji, Jing Ni, Nancy U. Lin, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 8, pp. 1795-1804
Open Access | Times Cited: 79
Sheheryar Kabraji, Jing Ni, Nancy U. Lin, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 8, pp. 1795-1804
Open Access | Times Cited: 79
Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Rupa Juthani, Brian Madajewski, Barney Yoo, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 1, pp. 147-158
Open Access | Times Cited: 73
Rupa Juthani, Brian Madajewski, Barney Yoo, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 1, pp. 147-158
Open Access | Times Cited: 73
Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
Kelsey Pan, Kyle Concannon, Jing Li, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 716-732
Closed Access | Times Cited: 22
Kelsey Pan, Kyle Concannon, Jing Li, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 716-732
Closed Access | Times Cited: 22
Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier
Nicola Colclough, Ravindra V. Alluri, James W. Tucker, et al.
Drug Metabolism and Disposition (2023) Vol. 52, Iss. 2, pp. 95-105
Open Access | Times Cited: 11
Nicola Colclough, Ravindra V. Alluri, James W. Tucker, et al.
Drug Metabolism and Disposition (2023) Vol. 52, Iss. 2, pp. 95-105
Open Access | Times Cited: 11
Impact of EGFR Mutation Subtypes and TKI Generations on Clinical Outcomes in Lung Adenocarcinoma Patients with Brain Metastases Treated with Gamma Knife Radiosurgery
Haewon Roh, Chan Hyuk Park, Won Shik Kim, et al.
Research Square (Research Square) (2025)
Closed Access
Haewon Roh, Chan Hyuk Park, Won Shik Kim, et al.
Research Square (Research Square) (2025)
Closed Access
Overview of metastatic disease of the central nervous system
Craig Nolan, Lisa M. DeAngelis
Handbook of clinical neurology (2018), pp. 3-23
Closed Access | Times Cited: 37
Craig Nolan, Lisa M. DeAngelis
Handbook of clinical neurology (2018), pp. 3-23
Closed Access | Times Cited: 37
Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery
Nicola Colclough, Kan Chen, Peter Johnström, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 5, pp. 1067-1073
Closed Access | Times Cited: 30
Nicola Colclough, Kan Chen, Peter Johnström, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 5, pp. 1067-1073
Closed Access | Times Cited: 30
Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors
Ulrich H. Weidle, Fabian Birzele, Georg Tiefenthaler
Cancer Genomics & Proteomics (2018) Vol. 15, Iss. 4, pp. 225-238
Open Access | Times Cited: 18
Ulrich H. Weidle, Fabian Birzele, Georg Tiefenthaler
Cancer Genomics & Proteomics (2018) Vol. 15, Iss. 4, pp. 225-238
Open Access | Times Cited: 18
Novel Systemic Treatments for Brain Metastases From Lung Cancer
Bicky Thapa, Adam Lauko, Kunal Desai, et al.
Current Treatment Options in Neurology (2018) Vol. 20, Iss. 11
Closed Access | Times Cited: 8
Bicky Thapa, Adam Lauko, Kunal Desai, et al.
Current Treatment Options in Neurology (2018) Vol. 20, Iss. 11
Closed Access | Times Cited: 8
Sequencing brain metastases and opportunities for targeted therapies
Ugonma Chukwueke, Priscilla K. Brastianos
Pharmacogenomics (2017) Vol. 18, Iss. 6, pp. 585-594
Closed Access | Times Cited: 7
Ugonma Chukwueke, Priscilla K. Brastianos
Pharmacogenomics (2017) Vol. 18, Iss. 6, pp. 585-594
Closed Access | Times Cited: 7
Chemotherapy for the Management of Cerebral Metastases
Chase H. Foster, Pooja Dave, Jonathan H. Sherman
Neurosurgery Clinics of North America (2020) Vol. 31, Iss. 4, pp. 603-611
Closed Access | Times Cited: 5
Chase H. Foster, Pooja Dave, Jonathan H. Sherman
Neurosurgery Clinics of North America (2020) Vol. 31, Iss. 4, pp. 603-611
Closed Access | Times Cited: 5
Influence of transporters in treating cancers in the CNS
Gautham Gampa, Surabhi Talele, Minjee Kim, et al.
Elsevier eBooks (2019), pp. 277-301
Closed Access | Times Cited: 3
Gautham Gampa, Surabhi Talele, Minjee Kim, et al.
Elsevier eBooks (2019), pp. 277-301
Closed Access | Times Cited: 3
Chemotherapy of Brain Metastases
Herbert B. Newton
Elsevier eBooks (2018), pp. 527-543
Closed Access | Times Cited: 1
Herbert B. Newton
Elsevier eBooks (2018), pp. 527-543
Closed Access | Times Cited: 1
Pomalidomide in primary intraocular lymphoma
Jan‐Paul Bohn, Wolfgang Willenbacher, Gertrud Haas, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2019) Vol. 60, Iss. 6, pp. 1584-1586
Closed Access | Times Cited: 1
Jan‐Paul Bohn, Wolfgang Willenbacher, Gertrud Haas, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2019) Vol. 60, Iss. 6, pp. 1584-1586
Closed Access | Times Cited: 1
Intracranial metastases
Herbert B. Newton, Seema Shroff, Mark G. Malkin
Elsevier eBooks (2022), pp. 79-95
Closed Access | Times Cited: 1
Herbert B. Newton, Seema Shroff, Mark G. Malkin
Elsevier eBooks (2022), pp. 79-95
Closed Access | Times Cited: 1
Data from Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
Nicola Colclough, Kan Chen, Peter Johnström, et al.
(2023)
Open Access
Nicola Colclough, Kan Chen, Peter Johnström, et al.
(2023)
Open Access
Data from Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
Nicola Colclough, Kan Chen, Peter Johnström, et al.
(2023)
Open Access
Nicola Colclough, Kan Chen, Peter Johnström, et al.
(2023)
Open Access
Metastatic Tumors
Serge Weis, Michael Sonnberger, Andreas Dunzinger, et al.
(2019), pp. 2025-2105
Closed Access
Serge Weis, Michael Sonnberger, Andreas Dunzinger, et al.
(2019), pp. 2025-2105
Closed Access
